Abstract |
The present study investigated the regional distribution of the N-methyl-D-aspartate ( NMDA) receptor containing the NR2B subunit protein in rat lumbar spinal cord and examined whether selective NR2B antagonists would exhibit antinociception with reduced side-effect liability than subtype non-selective NMDA antagonists and anticonvulsants. Immunocytochemical studies showed the NR2B subunit had a restricted distribution, with moderate labelling of fibres in laminas I and II of the dorsal horn suggesting a presynaptic location on primary afferent fibers and possible involvement in pain transmission. In the in vivo studies, the NMDA/ glycine antagonists ( MK-801, 0.02-1 mg/kg i.p., L-687,414 10-300 mg/kg i.p., and L-701,324 1-10 mg/kg i.p.) and the anticonvulsant, gabapentin (10-500 mg/kg p.o.), induced rotarod deficits at antinociceptive doses. In contrast, the selective NR2B antagonists, (+/-)- CP-101,606 (1-100 mg/kg p.o.) and (+/-)- Ro 25-6981 (3-100 mg/kg i.p.) showed a significant dose window. (+/-)- CP-101,606 caused no motor impairment or stimulation in rats at doses up to 100 mg/kg p.o., which is far in excess of those inhibiting allodynia in neuropathic rats (ID50 4.1 mg/kg, p.o.). (+/-)- Ro 25-6981 also showed a significant separation (ID50 allodynia 3.8 mg/kg, i.p.), however, some disruption of rotarod performance was observed at 100 mg/kg. The anticonvulsant lamotrigine (3-500 mg/kg p.o.) also showed a good dose window. These findings demonstrate that NR2B antagonists may have clinical utility for the treatment of neuropathic and other pain conditions in man with a reduced side-effect profile than existing NMDA antagonists.
|
Authors | S Boyce, A Wyatt, J K Webb, R O'Donnell, G Mason, M Rigby, D Sirinathsinghji, R G Hill, N M Rupniak |
Journal | Neuropharmacology
(Neuropharmacology)
Vol. 38
Issue 5
Pg. 611-23
(May 1999)
ISSN: 0028-3908 [Print] England |
PMID | 10340299
(Publication Type: Journal Article)
|
Chemical References |
- Acetates
- Amines
- Anticonvulsants
- Cyclohexanecarboxylic Acids
- Excitatory Amino Acid Antagonists
- Phenols
- Piperidines
- Pyrrolidinones
- Receptors, N-Methyl-D-Aspartate
- Ro 25-6981
- Triazines
- L 687414
- gamma-Aminobutyric Acid
- Gabapentin
- Dizocilpine Maleate
- traxoprodil mesylate
- ifenprodil
- Lamotrigine
|
Topics |
- Acetates
(pharmacology)
- Amines
- Animals
- Anticonvulsants
(pharmacology)
- Cyclohexanecarboxylic Acids
- Dizocilpine Maleate
(pharmacology)
- Excitatory Amino Acid Antagonists
(pharmacology, therapeutic use)
- Gabapentin
- Hyperalgesia
(drug therapy)
- Lamotrigine
- Male
- Motor Activity
(drug effects)
- Pain Measurement
(drug effects)
- Phenols
(pharmacology)
- Piperidines
(pharmacology)
- Pyrrolidinones
(pharmacology)
- Rabbits
- Rats
- Rats, Sprague-Dawley
- Receptors, N-Methyl-D-Aspartate
(antagonists & inhibitors, genetics)
- Spinal Cord
(cytology)
- Triazines
(pharmacology)
- gamma-Aminobutyric Acid
|